Unicycive Therapeutics, Inc. - UNCY
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 2,807,830 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 2,807,830 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 2,807,830 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 9.99% | 4,856,259 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 9.99% | 4,856,259 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 0.8% | 205,529 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 1.0% | 271,456 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 1.0% | 271,456 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Israel A. Englander | 1.0% | 271,456 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 2,801,082 | View |
| May 15, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 2,801,082 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 2,801,082 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 2,801,082 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.